Company: BSX
Filing Date: 2025-03-19
Form Type: DEF 14A
Source: 0000885725-25-000017
Chunk: 75

Company: BOSTON SCIENTIFIC CORP
Filing Date: 2025-03-19
Form: DEF 14A
Chunk 75
---
 |     | Michael J. Mahoney |     |                       130,118 |
|            |     | Daniel J. Brennan                                                                  |     |                                                                           33,944 |     |                    |     |                               |
|            |     | Arthur C. Butcher                                                                  |     |                                                                           20,366 |     |                    |     |                               |
|            |     | Joseph M. Fitzgerald                                                               |     |                                                                           31,680 |     |                    |     |                               |
|            |     |                                                                                    |     |                                                               Jeffery B. Mirviss |     |             23,760 |     |                               |

Primary Elements of Indirect Executive Compensation

We also compensate our executives, including our NEOs, with indirect compensation, namely in the form of benefits and limited perquisites. Generally, our benefits and perquisites are targeted to be competitive relative to our peer group companies. The primary elements of and objectives for our NEOs’ 2024 indirect compensation are summarized below.

#### General Employee Benefits
We provide employee benefits to eligible employees, including our NEOs, to promote personal health and well-being and to provide certain financial security and protection upon retirement or in the event of death, disability or illness. We also have an Employee Stock Purchase Plan available to eligible employees, including our NEOs, pursuant to which employees may purchase shares of our common stock at a 15% discount to the market price. As U.S.-based employees, our NEOs are eligible to receive employee benefits under our U.S. employee benefits program, which consists of the following key elements that are generally the same as those provided to our other U.S. salaried employees:

• health and welfare benefits, with a choice between a preferred provider model or a high-deductible plan with a Health Savings Account (executives share costs within a range of approximately 18% to 35% depending upon the plan and coverage selected);

• Company-paid term life insurance policies that provide a benefit equal to base salary, with a minimum benefit of $50,000 and a maximum benefit of up to $1.5 million, payable upon death; and

• a qualified 401(k) retirement plan, which includes an option to invest in a Company Stock Fund, with a Company match of up to 6% of eligible salary up to $345,000 in 2024 resulting in a maximum possible match of $20,700.

In addition, our executive officers may participate in an annual executive level physical examination program that is designed to